A Multifunctional Therapeutic Platform: Ce/Zn/Sr-Doped Mesoporous Bioactive Glass Nanoparticles for Bone Repair.

Nattakan Sae-Sue, Wen-Ta Su, Poommaree Namchaiw, Kamolchanok Ngamkham, Nattida Suwanakitti, Parichart Naruphontjirakul

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nattakan Sae-SueBiological Engineering Program, Faculty of Engineering, King Mongkut's University of Technology Thonburi, Bangkok 10140, Thailand.ORCID 0009-0009-6626-6462

Wen-Ta SuDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology, Taipei 106344, Taiwan.ORCID 0000-0001-7106-6320

Poommaree NamchaiwBiological Engineering Program, Faculty of Engineering, King Mongkut's University of Technology Thonburi, Bangkok 10140, Thailand.

Kamolchanok NgamkhamBiological Engineering Program, Faculty of Engineering, King Mongkut's University of Technology Thonburi, Bangkok 10140, Thailand.ORCID 0000-0003-4157-9138

Nattida SuwanakittiBiorefinery and Bioproduct Technology Research Group, National Center for Genetic Engineering and Biotechnology, Pathum Thani 12120, Thailand.ORCID 0009-0004-2994-132X

Parichart NaruphontjirakulBiological Engineering Program, Faculty of Engineering, King Mongkut's University of Technology Thonburi, Bangkok 10140, Thailand.ORCID 0000-0001-9998-6700

Funding

Asahi Glass Foundation - King Mongkut's University of Technology Thonburi, Fiscal year 2024King Mongkut's University of Technology Thonburi (KMUTT), Thailand Science Research and Innovation (TSRI), and National Science, Research and Innovation Fund (NSRF), Fiscal year 2025 FRB680074/0164National Taipei University of Technology - King Mongkut's University of Technology Thonburi Joint Research Program, Fiscal year 2024 NTUT- KMUTT-No.11303

6 · The paper itself

Abstract

Mesoporous bioactive glass nanoparticles (MBGNs) are promising for bone tissue engineering; however, surgical site infection and oxidative stress often compromise regeneration. To address this, MBGNs co-doped with cerium (Ce), zinc (Zn), and strontium (Sr) were synthesized using a microemulsion-assisted sol-gel route (xCe-yZn-Sr-MBGNs; x = 0, 1, 2; y = 0, 0.5, 1). The resulting spherical nanoparticles (150-200 nm) exhibited a mesoporous structure with a specific surface area of (~340-425 m

Indexed as

Bone RegenerationCeriumGlassNanoparticlesStrontiumZincAnimalsAnti-Bacterial AgentsBiocompatible MaterialsCell DifferentiationCell LineCell SurvivalMiceOsteoblastsOsteogenesisPorosityAnti-Bacterial AgentsBiocompatible MaterialsCeriumStrontiumZincantibacterialantioxidantbone regenerationmesoporous bioactive glass nanoparticlesnanoceria

Identifiers

PMID41898502

DOI10.3390/ijms27062640

PMCPMC13026452

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.